Biología molecular del cáncer
University of Sydney
Sídney, AustraliaPublicaciones en colaboración con investigadores/as de University of Sydney (6)
2021
-
Core Outcome Measures for Trials in People with Coronavirus Disease 2019: Respiratory Failure, Multiorgan Failure, Shortness of Breath, and Recovery
Critical Care Medicine, Vol. 49, Núm. 3, pp. 503-516
2019
-
Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer
JAMA network open, Vol. 2, Núm. 9, pp. e1911750
2016
-
Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
The Lancet Oncology, Vol. 17, Núm. 12, pp. 1709-1719
2015
-
Determinants of downloads and citations for articles published in intensive care medicine
Intensive Care Medicine Experimental
-
Outcome of manuscripts rejected from intensive care medicine: An in silico study
Intensive Care Medicine Experimental
2011
-
XELOX vs FOLFOX-4 as first-line therapy for metastatic colorectal cancer: NO16966 updated results
British Journal of Cancer, Vol. 105, Núm. 1, pp. 58-64